Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
11/07/2012 | EP2519250A1 Interferon analogs |
11/07/2012 | CN102766193A Colorectal cancer specific antigen peptide and colorectal cancer detection kit |
11/06/2012 | US8304521 Phospho-specific anti-Pax3 antibodies |
11/06/2012 | US8304519 Compositions and methods for modulating dopamine neurotransmission |
11/06/2012 | US8304393 Epithelial cell growth promoter |
11/06/2012 | US8304392 Pharmaceutical and/or cosmetic composition containing an active principle activator of cytochrome C |
11/06/2012 | US8304385 Macrocyclic tetrazolyl hepatitis C serine protease inhibitors |
11/06/2012 | US8304382 Anti-inflammatory and anti-allergic cyclic peptides |
11/06/2012 | US8303962 Antibacterial and antifungal peptides |
11/01/2012 | US20120277164 Gadd45beta targeting agents |
11/01/2012 | US20120277146 Compounds For Enzyme Inhibition |
11/01/2012 | US20120276052 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury |
10/31/2012 | EP2518079A2 HCV/HIV inhibitors and their uses |
10/31/2012 | CN102762586A Therapeutic peptides |
10/31/2012 | CN102757480A Anti-dengue virus type-4 neutralizing epitope-specific antibody and application of anti-dengue virus type-4 neutralizing epitope-specific antibody to treatment of dengue virus type-4 infection |
10/31/2012 | CN102757479A High-activity blood pressure lowering peptide and preparation method thereof |
10/31/2012 | CN102757478A Allyl cysteinyl amino acid derivative and synthesis method and application thereof |
10/31/2012 | CN102757477A Allyl cysteinyl amino acid methyl ester derivative and synthesis method and application thereof |
10/31/2012 | CN101538311B Alpha-amido acyl-ring imide peptoid metalloprotease inhibitor and application thereof |
10/31/2012 | CN101242816B Hcv inhibitors |
10/30/2012 | US8299213 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
10/30/2012 | US8299129 Peptide lipid-containing carrier and method for introducing compound into cells using same |
10/30/2012 | US8299094 Hepatitis C virus inhibitors |
10/30/2012 | US8299020 Antimicrobial peptides and methods of their use |
10/30/2012 | US8298759 Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents |
10/30/2012 | CA2549185C Peptide inhibiting angiotensin converting enzyme |
10/30/2012 | CA2445938C Hepatitis c inhibitor tri-peptides |
10/26/2012 | WO2012144546A1 Novel peptide |
10/26/2012 | WO2012142659A1 Site-selective modification of proteins |
10/26/2012 | WO2012097344A3 Metal abstraction peptide and uses thereof |
10/26/2012 | WO2012031250A8 Compositions for labeling nerves and methods of use |
10/26/2012 | WO2012019299A9 Hepatitis c inhibitor compounds |
10/25/2012 | US20120270813 Process for Preparing Peptide Products for Promoting Cholecystokinin Secretion and Use of the Peptide Products |
10/25/2012 | US20120270811 Conformations of divergent peptides with mineral binding affinity |
10/25/2012 | US20120270807 Macrocyclic inhibitors of serine protease enzymes |
10/25/2012 | US20120270802 Binding molecules for the treatment of myeloid cell malignancies |
10/25/2012 | US20120270795 Compounds for the treatment of diseases related to protein misfolding |
10/25/2012 | US20120270775 Crystalline forms of a potent hcv inhibitor |
10/25/2012 | US20120270774 Macrocyclic compounds, compositions comprising them and methods for preventing or treating hiv infection |
10/25/2012 | US20120270208 Synthetic antigens for the detection of antibodies to hepatitis c virus |
10/25/2012 | US20120269837 SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb) |
10/25/2012 | US20120269797 Method for inhibiting the maturation of dendritic cells |
10/25/2012 | US20120269769 Hepatitis C Inhibitor Compounds |
10/24/2012 | CN102753042A Flavor-enriching agent |
10/24/2012 | CN102753041A Flavor-enriching agent |
10/23/2012 | US8293704 Crystalline form of linaclotide |
10/23/2012 | US8293702 Phenolic binding peptides |
10/23/2012 | CA2334679C Pyrazinone protease inhibitors |
10/18/2012 | WO2012140619A1 Compounds binding to the bacterial beta ring |
10/18/2012 | WO2012140500A1 Selective cysteine protease inhibitors and uses thereof |
10/18/2012 | US20120264696 Prevention of cellular senescence in mammals by natural peptide complexes |
10/18/2012 | US20120264676 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
10/18/2012 | US20120263654 Melanoma specific biomarker |
10/18/2012 | CA2833082A1 Selective cysteine protease inhibitors and uses thereof |
10/18/2012 | CA2832695A1 Compounds binding to the bacterial beta ring |
10/17/2012 | EP2511290A1 Compounds binding to the bacterial beta ring |
10/17/2012 | EP2509614A1 Antimicrobial water treatment membranes and production thereof |
10/17/2012 | CN102741270A Cyclic peptide inhibitors of hepatitis c virus replication |
10/17/2012 | CN102741269A Gadd45beta targeting agents |
10/17/2012 | CN102740896A Igf-i poly (ethylene glycol) conjugates |
10/17/2012 | CN102731628A Method for preparing romurtide |
10/17/2012 | CN102731614A Collagen tripeptide chelated calcium and its preparation method |
10/17/2012 | CN102731613A Preparation method of L-alanyl-L-glutamine |
10/17/2012 | CN101948507B Novel anti-cancer medicaments using NGR(NO2) as targeting carrier, preparation thereof and use thereof |
10/17/2012 | CN101906138B Pseudo cyclic polypeptide and synthesis method and application thereof |
10/17/2012 | CN101875683B Small molecule peptide-based cholesteric organic gel molecules and preparation method thereof |
10/17/2012 | CN101466727B Hcv/hiv inhibitor and their uses |
10/16/2012 | US8288510 Isolated peptides having phospholipase inhibitory activity |
10/16/2012 | US8288509 Therapeutic agent for infections, and treatment method using the same |
10/16/2012 | US8288336 Treatment of subarachnoid hemorrhage with ApoE analogs |
10/16/2012 | US8288335 ApoE analogs and methods for their use |
10/16/2012 | US8287875 Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor |
10/11/2012 | WO2012137824A1 Process for producing reduced glutathione |
10/11/2012 | US20120258550 Regulation of autophagy pathway phosphorylation and uses thereof |
10/11/2012 | US20120258490 Process for producing dipeptides or dipeptide derivatives |
10/11/2012 | US20120258059 Cosmetic, external skin preparation, and medical instrument |
10/11/2012 | US20120258043 Linkable Lewis X Analogs |
10/10/2012 | CN1973053B Novel anti-IL 13 antibodies and uses thereof |
10/10/2012 | CN102725001A Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
10/10/2012 | CN102718834A Specific inhibitor of human immune system toxic protein granzyme H, its preparation method and application |
10/10/2012 | CN102718833A Preparation method of glycyl-tyrosine |
10/10/2012 | CN101472939B Pseudo proline dipeptides |
10/10/2012 | CN101287988B Methods and compositions for diagnosis and treatment of influenza |
10/09/2012 | US8283444 Non-viral delivery of compounds to mitochondria |
10/09/2012 | CA2358517C Method and composition for angiogenesis inhibition |
10/09/2012 | CA2164698C Synthetic peptide inhibitors of hiv transmission |
10/04/2012 | WO2012135846A1 Methods of eradicating bacterial cell populations |
10/04/2012 | WO2012131377A1 Macrocyclic compounds and methods for their production |
10/04/2012 | WO2012131371A1 Macrocyclic compound and methods for its production |
10/04/2012 | WO2012129680A1 Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma- glutamyl-l-tryptophan |
10/04/2012 | WO2012129671A1 Prodrugs of d-isoglutamyl-[d/l]-tryptophan |
10/04/2012 | US20120253042 Use of ruthenium complexes for formation and/or hydrogenation of amides and related carboxylic acid derivatives |
10/04/2012 | US20120252743 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa |
10/04/2012 | US20120252739 Tubulin Inhibitors |
10/04/2012 | US20120252738 Tubulin Inhibitors |
10/04/2012 | US20120252734 Inhibitors of antigen presentation by mhc class ii molecules |
10/04/2012 | US20120252730 Platelet aggregation inhibitors |
10/04/2012 | US20120251581 Novel Compound and Methods for its Production |
10/04/2012 | US20120251493 Novel macrocyclic inhibitors of hepatitis c virus replication |
10/04/2012 | CA2831429A1 Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma- glutamyl-l-tryptophan |